nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Affinity fingerprints – leading the way?
|
Bajorath, Jürgen |
|
2002 |
7 |
20 |
p. 1035- 1 p. |
artikel |
2 |
Anti-infectives in the 21st century
|
Clough, Joanne |
|
2002 |
7 |
20 |
p. 1036-1038 3 p. |
artikel |
3 |
Application of hydrogen bonding calculations in property based drug design
|
Abraham, Michael H |
|
2002 |
7 |
20 |
p. 1056-1063 8 p. |
artikel |
4 |
Biomedical informatics: the future for drug development
|
Liebman, Michael N. |
|
2002 |
7 |
20 |
p. s197-s203 nvt p. |
artikel |
5 |
Boost for retinoic acid cancer therapy
|
Habeck, Martina |
|
2002 |
7 |
20 |
p. 1024-1025 2 p. |
artikel |
6 |
Effective experimental design: enzyme kinetics in the bioinformatics era
|
Murphy, Emma F |
|
2002 |
7 |
20 |
p. s187-s191 nvt p. |
artikel |
7 |
From microarrays to networks: mining expression time series
|
Dewey, T.Gregory |
|
2002 |
7 |
20 |
p. s170-s175 nvt p. |
artikel |
8 |
Grid technologies empowering drug discovery
|
Chien, Andrew |
|
2002 |
7 |
20 |
p. s176-s180 nvt p. |
artikel |
9 |
Industrialized molecular biology, information biotechnology, and the blockbuster drug model – alive and well at age 50
|
Augen, Jeffrey |
|
2002 |
7 |
20 |
p. s157-s159 nvt p. |
artikel |
10 |
Knowledge assembly for the life sciences
|
Neumann, Eric |
|
2002 |
7 |
20 |
p. s160-s162 nvt p. |
artikel |
11 |
Leveraging process integration in early drug discovery
|
Fay, Nicolas |
|
2002 |
7 |
20 |
p. s181-s186 nvt p. |
artikel |
12 |
Methods in Genomic Neuroscience
|
Jain, Meena |
|
2002 |
7 |
20 |
p. 1038-1039 2 p. |
artikel |
13 |
Microbes, viruses and verse – microbial musings
|
Rowe, Raymond C |
|
2002 |
7 |
20 |
p. 1032-1033 2 p. |
artikel |
14 |
Monitor: molecules and profiles
|
Barlocco, Daniela |
|
2002 |
7 |
20 |
p. 1064-1065 2 p. |
artikel |
15 |
News in brief
|
Ashton, Vicky |
|
2002 |
7 |
20 |
p. 1027-1030 4 p. |
artikel |
16 |
Novel antiviral molecules
|
Walker, Michael A |
|
2002 |
7 |
20 |
p. 1065-1066 2 p. |
artikel |
17 |
People
|
Clough, Joanne |
|
2002 |
7 |
20 |
p. 1031- 1 p. |
artikel |
18 |
Pretzel-shaped peptide for autoimmune disease
|
Sutherland, Stephani |
|
2002 |
7 |
20 |
p. 1023-1024 2 p. |
artikel |
19 |
Rational drug discovery: what can we learn from regulatory networks?
|
Huang, Sui |
|
2002 |
7 |
20 |
p. s163-s169 nvt p. |
artikel |
20 |
RNAi: gene-silencing in therapeutic intervention
|
Shuey, David J |
|
2002 |
7 |
20 |
p. 1040-1046 7 p. |
artikel |
21 |
Small- and large-scale biosimulation applied to drug discovery and development
|
Musante, C.J |
|
2002 |
7 |
20 |
p. s192-s196 nvt p. |
artikel |
22 |
Structure-based virtual screening: an overview
|
Lyne, Paul D |
|
2002 |
7 |
20 |
p. 1047-1055 9 p. |
artikel |
23 |
Top of the form
|
Brown, Matt |
|
2002 |
7 |
20 |
p. 1026-1027 2 p. |
artikel |
24 |
Towards a reconciliation between molecular diagnostics and new pharmaceuticals
|
Gold, Bert |
|
2002 |
7 |
20 |
p. 1034-1035 2 p. |
artikel |